Lisdexamfetamin-Mepha 20 mg
Lisdexamfetamin-Mepha 20 mg is a medicine authorised by Swissmedic under authorisation number 70022. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 06 November 2025 and the authorisation is limited until 05 November 2030. ATC code N06BA12 places the medicine in the group Psychoanaleptics.
| Authorisation number | 70022 |
|---|---|
| Name | Lisdexamfetamin-Mepha 20 mg |
| Full name | Lisdexamfetamin-Mepha 20 mg, Hartkapseln |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N06BA12 |
| First authorisation | 06 November 2025 |
| Authorisation validity | 05 November 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lisdexamfetamin-Mepha 20 mg, Hartkapseln | A+ | 06 November 2025 |
| 2 | Lisdexamfetamin-Mepha 30 mg, Hartkapseln | A+ | 06 November 2025 |
| 3 | Lisdexamfetamin-Mepha 40 mg, Hartkapseln | A+ | 06 November 2025 |
| 4 | Lisdexamfetamin-Mepha 50 mg, Hartkapseln | A+ | 06 November 2025 |
| 5 | Lisdexamfetamin-Mepha 60 mg, Hartkapseln | A+ | 06 November 2025 |
| 6 | Lisdexamfetamin-Mepha 70 mg , Hartkapseln | A+ | 06 November 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
| 2 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
| 3 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
| 4 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
| 5 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
| 6 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lisdexamfetamin-Mepha 20 mg authorised in Switzerland?
Yes. Lisdexamfetamin-Mepha 20 mg is authorised by Swissmedic under authorisation number 70022, data as of 01 September 2026. The authorisation is limited until 05 November 2030.
Which dispensing category does Lisdexamfetamin-Mepha 20 mg have?
Lisdexamfetamin-Mepha 20 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Lisdexamfetamin-Mepha 20 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.